Key result
Non-apical RVP shows no clinical benefit over apical pacing for death or HF hospitalization.
Why the study?
Does non-RVA pacing improve clinical outcomes compared to RVA pacing in patients with high-grade atrioventricular block requiring dual-chamber pacemaker implantation?
Observational (n=437)
Single-blind
Nonrandomized
Yes
Does non-RVA pacing improve clinical outcomes compared to RVA pacing in patients with high-grade atrioventricular block requiring dual-chamber pacemaker implantation?
In patients requiring dual-chamber pacing with a high percentage of RV pacing, non-apical RV pacing did not significantly improve clinical outcomes compared to traditional apical pacing.
Answers are grounded in this paper and cite their sources.
No outcome benefit with non-apical versus apical RV pacing in this cohort; leaves open superiority in high-grade AV block.
Objective. The aim of the study was to compare the two approaches to chronic right ventricular pacing currently adopted in clinical practice: right ventricular apical (RVA) and non-RVA pacing. Background. Chronic RVA pacing is associated with an increased risk of atrial fibrillation, morbidity, and even mortality. Non-RVA pacing may yield more physiologic ventricular activation and provide potential long-term benefits and has recently been adopted as standard procedure at many implanting centers. Methods. The Right Pace study was a multicenter, prospective, single-blind, nonrandomized trial involving 437 patients indicated for dual-chamber pacemaker implantation with a high percentage of RV pacing. Results. RV lead-tip target location was the apex or the interventricular septum. RVA (274) and non-RVA patients (163) did not differ in baseline characteristics. During a median follow-up of 19 months (25th–75th percentiles, 13–25), 17 patients died. The rates of the primary outcome of death due to any cause or hospitalization for heart failure were comparable between the groups (log-rank test, p=0.609 ), as were the rates of the composite of death due to any cause, hospitalization for heart failure, or an increase in left ventricular end-systolic volume ≥ 15% as compared with the baseline evaluation (secondary outcome, p=0.703 ). After central adjudication of X-rays, comparison between adjudicated RVA (239 patients) and non-RVA (170 patients) confirmed the absence of difference in the rates of primary ( p=0.402 ) and secondary ( p=0.941 ) outcome. Conclusions. In patients with indications for dual-chamber pacemaker who require a high percentage of ventricular stimulation, RVA or non-RVA pacing resulted in comparable outcomes. This study is registered with ClinicalTrials.gov (identifier: NCT01647490 ).
No takes yet. Share an insight, caveat, or question.
Muto et al. (2018) conducted an observational in High-grade atrioventricular block requiring dual-chamber pacemaker implantation (n=437). Non-right ventricular apical (non-RVA) septal pacing vs. Right ventricular apical (RVA) pacing was evaluated on Composite of death due to any cause or hospitalization for heart failure (HR 1.30, 95% CI 0.50-3.38, p=0.609). Non-apical right ventricular pacing resulted in comparable rates of all-cause death or heart failure hospitalization compared to apical pacing.
Synapse has enriched 10 related papers. Consider them for comparative context: